Number of patients with a significant increase or significant decrease between the baseline measurement (SCr-BL) and the creatinine measurement at emergency department presentation (SCr-ED). by M. S. A. Niemantsverdriet (11886431)

Variants with an unknown significance or conflicting interpretation of clinical significance. by J. Tyson McDonald (3687694)

Subjects:

GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

“…<p>GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value).</p>…”

List of 1483 genes that were significantly (<i>P</i> < 0.1) increased or decreased in any galactose-treated sample. by Masaya Nagaya (13851123)

Subjects:

Top 20 genes with significantly increased abundance in Aco^R cells. by Pieter C. Steketee (10024552)

The windows show the final results reflecting the increase or decrease in the GRF and JRF calculations. by Amany Eid Abd El-Tawab (13864185)

OS correlation of differentially expressed miRNAs (> 2-fold increase or decrease in HCC vs normal livers), according to KMP; miRNAs in bold are significantly correlated with OS. by Kayleigh Smith (17816667)

“…<p>OS correlation of differentially expressed miRNAs (> 2-fold increase or decrease in HCC vs normal livers), according to KMP; miRNAs in bold are significantly correlated with OS.…”

Number and % of participants demonstrating a clinically-significant difference on RMSSD HRV (comparing compassion or relaxation task to control). by Iona Naismith (14581268)

Subjects:

List of 421 genes whose expression is increased by galactose and decreased by any of the HAT inhibitors. by Masaya Nagaya (13851123)

Subjects:

List of 412 genes whose expression is decreased by galactose and increased by any of the HAT inhibitors. by Masaya Nagaya (13851123)

Subjects:

Nasal microbiota features significantly associate with the presence of clinical signs. by Holly Kristin Arnold (14204655)

Gut microbiota features significantly associate with the presence of clinical signs. by Holly Kristin Arnold (14204655)

Differentially expressed genes (DEGs) exhibiting both increased and decreased expression levels. by Liwen Wang (276995)

MAF1 protein expression is significantly decreased in luminal, HER2-positive, and TNBC breast cancer subtypes. by Stephanie Cabarcas-Petroski (9631636)

Subjects:

Predictors of higher-level coronary hyperemic DPV increase after PCI (>50% increase). by Eisuke Usui (12111855)

Subjects:

Summary of metabolites with statistically significant association with mortality at 6 months. by Aleksi J. Nummela (18764801)

Subjects:

Demographic, biochemical and clinical characteristics of the study groups. by Azza Elamir (13924199)

Subjects:

Species richness decreases significantly with increasing percent disturbance. by Catherine L. Cardelús (6429320)

Metformin increases PGC-1α and TFAM expression. by Joel R. Frandsen (20685133)

MAF1 mRNA expression significantly increases in SKBR3 and BT474 breast cancer cell lines treated with anti-HER2 therapies. by Stephanie Cabarcas-Petroski (9631636)

Subjects: